Laurus Labs Q2 outlook: On the EBITDA front, analysts at Kotak Institutional Equities build in 67% YoY growth to ₹680 crore in Q2FY27 with EBITDA margin expansion of 680 bps to 31.2%.
Laurus Labs Q2 outlook: On the EBITDA front, analysts at Kotak Institutional Equities build in 67% YoY growth to ₹680 crore in Q2FY27 with EBITDA margin expansion of 680 bps to 31.2%.
<iframe src="https://hindustansphere.com/embed/cluster/cc6a16b687dffba8a261c6f0584f35db3998b2d1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Laurus Labs zooms 128% from March low; hits new high in weak market"></iframe>
